Study on clinical effect of viable bifidobacterium combined with montmorillonite powder in the treatment of infantile diarrhea / 中国基层医药

ABSTRACT

Objective To study the clinical efficacy of viable bifidobacterium combined with montmorillonite powder in the treatment of infantile diarrhea.Methods 100 patients with infantile diarrhea disease were randomly divided into control group and observation group,50 cases in each group.The control group was given montmorillonitc powder treatment,while the observation group was added viable bifidobacterium treatment based on control group.Effi-cacy,serum C reactive protein (CRP)level,clinical symptom improvement time and adverse reactions rate were com-pared between two groups.Results The total effective rates of clinical treatment in the control group and observation group were 78%(39 /50)and 96%(48 /50)(P1 =0.026).After treatment,the treatment time,diarrhea stopping time,body temperature returned to normal,frequency of defecate recovery time,shape of defecate recovery time and scrum CRP levels in the control group were (8.73 ±1.92)d,(2.32 ±0.85)d,(27.53 ±7.24)h,(2.52 ±0.85)d, (3.62 ±1.23)d and (13.63 ±2.15)mg/L,which in observation group were (6.15 ±1.26)d,(1.53 ±0.62)d, (19.65 ±5.71)h,(1.75 ±0.76)d,(2.56 ±0.85)d and (7.52 ±1.26)mg/L.The observation group were better than the control group (P2 =0.026,P3 =0.018,P4 =0.021,P5 =0.012,P6 =0.031,P10 =0.002).The incidence of adverse reactions between two groups had no obvious difference.Conclusion Viable bifidobacterium combined with montmorillonite powder can effectively treat infantile diarrhea,with advantages of significant clinical efficacy,quickly recovery of clinical symptoms,rapidly reduce of CRP level,and low adverse reactions,it is worthy of promotion.